Block GA - Search Results

1

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA. Isakova T, et al. Among authors: block ga. J Am Soc Nephrol. 2015 Oct;26(10):2328-39. doi: 10.1681/ASN.2015020117. Epub 2015 May 12. J Am Soc Nephrol. 2015. PMID: 25967123 Free PMC article. Review.

2

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Block GA, et al. J Am Soc Nephrol. 2004 Aug;15(8):2208-18. doi: 10.1097/01.ASN.0000133041.27682.A2. J Am Soc Nephrol. 2004. PMID: 15284307

3

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.

Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P. Chertow GM, et al. Among authors: block ga. Clin J Am Soc Nephrol. 2007 Sep;2(5):898-905. doi: 10.2215/CJN.04381206. Epub 2007 Aug 16. Clin J Am Soc Nephrol. 2007. PMID: 17702710

4

Phosphate REINs in the renoprotective benefit of ACE inhibition.

Block GA, Wolf M. Block GA, et al. J Am Soc Nephrol. 2011 Oct;22(10):1777-9. doi: 10.1681/ASN.2011080833. Epub 2011 Sep 8. J Am Soc Nephrol. 2011. PMID: 21903991 No abstract available.

5

Effects of phosphate binders in moderate CKD.

Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM. Block GA, et al. J Am Soc Nephrol. 2012 Aug;23(8):1407-15. doi: 10.1681/ASN.2012030223. Epub 2012 Jul 19. J Am Soc Nephrol. 2012. PMID: 22822075 Free PMC article. Clinical Trial.

6

Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation.

Block GA, Ix JH, Ketteler M, Martin KJ, Thadhani RI, Tonelli M, Wolf M, Jüppner H, Hruska K, Wheeler DC. Block GA, et al. Am J Kidney Dis. 2013 Sep;62(3):457-73. doi: 10.1053/j.ajkd.2013.03.042. Epub 2013 Jun 12. Am J Kidney Dis. 2013. PMID: 23763855 Review.

7

CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.

Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD. Block GA, et al. Clin J Am Soc Nephrol. 2013 Dec;8(12):2132-40. doi: 10.2215/CJN.04260413. Epub 2013 Sep 19. Clin J Am Soc Nephrol. 2013. PMID: 24052218 Free PMC article.

8

Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD.

Yokoyama K, Hirakata H, Akiba T, Fukagawa M, Nakayama M, Sawada K, Kumagai Y, Block GA. Yokoyama K, et al. Among authors: block ga. Clin J Am Soc Nephrol. 2014 Mar;9(3):543-52. doi: 10.2215/CJN.05170513. Epub 2014 Jan 9. Clin J Am Soc Nephrol. 2014. PMID: 24408120 Free PMC article. Clinical Trial.

9

Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equation.

Robinson-Cohen C, Ix JH, Smits G, Persky M, Chertow GM, Block GA, Kestenbaum BR. Robinson-Cohen C, et al. Among authors: block ga. J Ren Nutr. 2014 May;24(3):194-9. doi: 10.1053/j.jrn.2014.02.001. J Ren Nutr. 2014. PMID: 24759300 Clinical Trial.

10

Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study.

Ix JH, Anderson CA, Smits G, Persky MS, Block GA. Ix JH, et al. Among authors: block ga. Am J Clin Nutr. 2014 Nov;100(5):1392-7. doi: 10.3945/ajcn.114.085498. Epub 2014 Aug 27. Am J Clin Nutr. 2014. PMID: 25332338 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters